STOCK TITAN

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Incyte (INCY) has announced the granting of restricted stock unit awards (RSUs) to 15 new employees, totaling 7,259 shares of common stock. The grants were made under the company's 2024 Inducement Stock Incentive Plan, with both grant date and vesting commencement date set for December 2, 2024. The compensation committee approved these awards as employment inducements in compliance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest in four equal annual installments of 25% each, contingent upon continued employment with the company.

Incyte (INCY) ha annunciato l'assegnazione di premi in unità di azioni riservate (RSU) a 15 nuovi dipendenti, per un totale di 7.259 azioni ordinarie. I premi sono stati concessi nell'ambito del Piano di Incentivazione Azionaria per l'Induzione 2024 dell'azienda, con la data di concessione e la data di inizio dell'acquisizione fissate per il 2 dicembre 2024. Il comitato per i compensi ha approvato questi premi come incentivi all'assunzione in conformità con la Regola di Quotazione Nasdaq 5635(c)(4). Le RSU si acquisiranno in quattro rate annuali uguali del 25% ciascuna, subordinate al mantenimento dell'impiego presso l'azienda.

Incyte (INCY) ha anunciado la concesión de premios en unidades de acciones restringidas (RSU) a 15 nuevos empleados, totalizando 7,259 acciones comunes. Las concesiones se realizaron bajo el Plan de Incentivos Accionarios por Inducción 2024 de la compañía, con la fecha de concesión y la fecha de inicio de adquisición fijadas para el 2 de diciembre de 2024. El comité de compensación aprobó estos premios como incentivos laborales en cumplimiento con la Regla de Cotización Nasdaq 5635(c)(4). Las RSU se adquirirán en cuatro cuotas anuales iguales del 25% cada una, condicionadas a la continuidad del empleo con la compañía.

Incyte (INCY)는 15명의 신입 사원에게 제한된 주식 단위 보상(RSU)을 부여했다고 발표했습니다. 총 7,259주의 보통주가 포함됩니다. 이 보상은 회사의 2024 유인 주식 인센티브 계획에 따라 이루어졌으며, 부여일 및 권리 취득 시작일은 2024년 12월 2일로 설정되었습니다. 보상 위원회는 이 보상을 Nasdaq 상장 규칙 5635(c)(4)에 따라 고용 유인을 위해 승인했습니다. RSU는 회사에 계속 고용된 경우에 한해 연간 25%씩 4회에 걸쳐 취득됩니다.

Incyte (INCY) a annoncé l'octroi d'unités d'actions restreintes (RSU) à 15 nouveaux employés, totalisant 7 259 actions ordinaires. Les attributions ont été faites dans le cadre du Plan d'Incitation à l'Action Sociétaire pour 2024 de l'entreprise, avec la date d'attribution et la date de début de l'acquisition fixées au 2 décembre 2024. Le comité de rémunération a approuvé ces attributions comme incitatifs à l'emploi conformément à la règle 5635(c)(4) de la cotation Nasdaq. Les RSU seront acquises en quatre versements annuels égaux de 25 % chacun, sous réserve d'un emploi continu au sein de l'entreprise.

Incyte (INCY) hat die Vergabe von eingeschränkten Aktieneinheiten (RSUs) an 15 neue Mitarbeiter bekannt gegeben, die insgesamt 7.259 Stammaktien umfassen. Die Vergaben erfolgten im Rahmen des 2024 Inducement Stock Incentive Plans des Unternehmens, wobei sowohl das Vergabedatum als auch der Vesting-Beginn auf den 2. Dezember 2024 festgelegt wurden. Der Vergütungsausschuss genehmigte diese Auszeichnungen als Beschäftigungsanreize in Übereinstimmung mit der Nasdaq-Listing-Regel 5635(c)(4). Die RSUs werden in vier gleichen jährlichen Raten von jeweils 25 % übertragen, abhängig von einer fortdauernden Anstellung bei dem Unternehmen.

Positive
  • Company demonstrates ability to attract new talent with equity compensation
Negative
  • Potential shareholder dilution from issuance of 7,259 new shares

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 7,259 shares of the Company’s common stock to 15 new employees. The awards were made under the Company’s 2024 Inducement Stock Incentive Plan, with a grant date and vesting commencement date of December 2, 2024, and were approved by the compensation committee of the Company’s board of directors as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).

Each RSU vests as to 25% of the shares subject to the RSU on each of the first four anniversaries of the vesting commencement date, subject to the employee's continued service with the Company on each such date.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Media

media@incyte.com

Investors

ir@incyte.com

Source: Incyte

FAQ

How many RSUs did Incyte (INCY) grant to new employees in December 2024?

Incyte granted RSUs representing 7,259 shares of common stock to 15 new employees.

What is the vesting schedule for Incyte's (INCY) December 2024 RSU grants?

The RSUs vest 25% annually over four years, with each portion vesting on the anniversary of the December 2, 2024 commencement date.

Under which plan did Incyte (INCY) issue the December 2024 RSU grants?

The RSUs were granted under Incyte's 2024 Inducement Stock Incentive Plan.

Incyte Genomics Inc

NASDAQ:INCY

INCY Rankings

INCY Latest News

INCY Stock Data

13.18B
188.31M
2.04%
97.8%
3.63%
Biotechnology
Services-commercial Physical & Biological Research
Link
United States of America
WILMINGTON